We are live on ! Find out more
FFTY icon

CapForce IBD 50 ETF

19 hedge funds and large institutions have $6.92M invested in CapForce IBD 50 ETF in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

18% more capital invested

Capital invested by funds: $5.86M → $6.92M (+$1.06M)

1.92% more ownership

Funds ownership: 17.05%18.97% (+1.9%)

0% more funds holding

Funds holding: 1919 (0)

Holders
19
Holders Change
Holders Change %
0%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
7
Reduced
5
Closed
3
Calls
Puts
Net Calls
Net Calls Change

FFTY Hedge Fund Activity: Q3 2016 in Review

19 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q3 2016, worth a combined $6.92M — up 18% from $5.86M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new FFTY positions and 3 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.

The largest buyer was UBS Group, adding an estimated $464K. The largest seller was CLA (CliftonLarsonAllen) Wealth Advisors, cutting an estimated $326K.

  • 19 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $6.92M of CapForce IBD 50 ETF stock for Q3 2016, up 18% quarter-over-quarter.
  • 4 funds opened new CapForce IBD 50 ETF positions in Q3 2016 and 3 closed out, a net change of +1 holder.
  • The largest CapForce IBD 50 ETF buyer in Q3 2016 was UBS Group, an estimated $464K added.
  • The largest CapForce IBD 50 ETF seller in Q3 2016 was CLA (CliftonLarsonAllen) Wealth Advisors, an estimated $326K sold.

Based on aggregated 13F filings for Q3 2016.